1
3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer
Condition(s):Lung CancerLast Updated:May 15, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Lung CancerLast Updated:May 15, 2013Completed
Condition(s):Prostate CancerLast Updated:May 15, 2013Completed
Condition(s):Gastric CancerLast Updated:May 15, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.